Abstract | BACKGROUND: PATIENTS AND METHODS: We genotyped the following polymorphisms in 372 CRC patients: TS enhancer region (TSER), TS 1494del6, MTHFR 677C>T and 1298A>C, and RFC1 -43T>C, 80G>A, and 696C>T. Using Kaplan-Meier curves, log-rank tests, and Cox proportional hazard models, we evaluated associations between these polymorphisms and overall survival (OS). RESULTS: The combined TS 1494 0bp6bp+6bp6bp genotype was associated with reduced OS compared to the TS 1494 0bp0bp genotype. Among rectal cancer patients, the RFC1 -43CC and 80AA genotypes were associated with favorable OS. CONCLUSIONS: Our data suggest that TS and RFC1 polymorphisms are associated with CRC prognosis in Korean patients. Further studies are needed to verify these findings.
|
Authors | Moon Ju Jang, Jong Woo Kim, Young Joo Jeon, So Young Chong, Sung Pyo Hong, Seong Gyu Hwang, Doyeun Oh, Yun Kyung Cho, Young Geon Ji, Nam Keun Kim |
Journal | Gene
(Gene)
Vol. 533
Issue 2
Pg. 558-64
(Jan 10 2014)
ISSN: 1879-0038 [Electronic] Netherlands |
PMID | 24100087
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2013 Elsevier B.V. All rights reserved. |
Chemical References |
- Reduced Folate Carrier Protein
- SLC19A1 protein, human
- Folic Acid
- MTHFR protein, human
- Methylenetetrahydrofolate Reductase (NADPH2)
- Thymidylate Synthase
- Fluorouracil
|
Topics |
- Aged
- Asian People
(genetics)
- Colorectal Neoplasms
(drug therapy, genetics, mortality)
- Female
- Fluorouracil
(pharmacokinetics, therapeutic use)
- Folic Acid
(metabolism)
- Humans
- Male
- Metabolic Networks and Pathways
(genetics)
- Methylenetetrahydrofolate Reductase (NADPH2)
(genetics)
- Middle Aged
- Polymorphism, Genetic
- Population
(genetics)
- Reduced Folate Carrier Protein
(genetics)
- Republic of Korea
(epidemiology)
- Survival Analysis
- Thymidylate Synthase
(genetics)
|